Position in ANRO
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$14,725
+$2,182 QoQ
Shares Held
558
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#99
of 113 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Torren Management, LLC holds $105,160 across 32 Biotechnology names. ANRO ranks #2 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
285 | $15,979 | |
| 2 | ANRO |
Alto Neuroscience, Inc.
This page
|
558 | $14,725 | |
| 3 | INBX |
Inhibrx Biosciences, Inc.
|
110 | $10,422 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
465 | $8,091 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
35 | $6,554 | |
| 6 | CTNM |
Contineum Therapeutics, Inc.
|
254 | $4,163 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8 | $3,973 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
30 | $3,677 |
All Filings in ANRO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,725 | 558 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $12,543 | 558 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $62,015 | 3,484 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||